These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8712133)

  • 1. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial).
    Becker RC; Cannon CP; Bovill EG; Tracy RP; Thompson B; Knatterud GL; Randall A; Braunwald B
    Am J Cardiol; 1996 Jul; 78(2):142-7. PubMed ID: 8712133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators.
    Becker RC; Cannon CP; Tracy RP; Thompson B; Bovill EG; Desvigne-Nickens P; Randall AM; Knatternud G; Braunwald E
    Am Heart J; 1996 Mar; 131(3):421-33. PubMed ID: 8604620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
    Cohen M; Xiong J; Parry G; Adams PC; Chamberlain D; Wieczorek I; Fox KA; McBride R; Chesebro JH; Fuster V
    J Am Coll Cardiol; 1993 Nov; 22(5):1338-43. PubMed ID: 7901254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein (a) blood levels in unstable angina pectoris, acute myocardial infarction, and after thrombolytic therapy.
    Qiu SQ; Théroux P; Genest J; Solymoss BC; Robitaille D; Marcil M
    Am J Cardiol; 1991 Jun; 67(15):1175-9. PubMed ID: 1827942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction.
    Hochman JS; McCabe CH; Stone PH; Becker RC; Cannon CP; DeFeo-Fraulini T; Thompson B; Steingart R; Knatterud G; Braunwald E
    J Am Coll Cardiol; 1997 Jul; 30(1):141-8. PubMed ID: 9207635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.
    Circulation; 1994 Apr; 89(4):1545-56. PubMed ID: 8149520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial.
    Montalescot G; Philippe F; Ankri A; Vicaut E; Bearez E; Poulard JE; Carrie D; Flammang D; Dutoit A; Carayon A; Jardel C; Chevrot M; Bastard JP; Bigonzi F; Thomas D
    Circulation; 1998 Jul; 98(4):294-9. PubMed ID: 9711933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
    An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of fibrinogen in patients admitted with suspected unstable angina and non-q-wave myocardial infarction].
    Arnau Vives MA; Rueda Soriano J; Martínez Dolz LV; Osa Sáez A; Almenar Bonet L; Morillas Blasco P; Osca Asensi J; Quesada Carmona A; Sanjuán Máñez R; Palencia Pérez MA
    Rev Esp Cardiol; 2002 Jun; 55(6):622-30. PubMed ID: 12113721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes.
    Abrignani MG; Novo G; Di Girolamo A; Caruso R; Tantillo R; Braschi A; Braschi GB; Strano A; Novo S
    Cardiologia; 1999 Dec; 44(12):1047-52. PubMed ID: 10687254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB).
    Cannon CP; McCabe CH; Stone PH; Schactman M; Thompson B; Theroux P; Gibson RS; Feldman T; Kleiman NS; Tofler GH; Muller JE; Chaitman BR; Braunwald E
    Am J Cardiol; 1997 Feb; 79(3):253-8. PubMed ID: 9036740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia.
    Cannon CP; McCabe CH; Stone PH; Rogers WJ; Schactman M; Thompson BW; Pearce DJ; Diver DJ; Kells C; Feldman T; Williams M; Gibson RS; Kronenberg MW; Ganz LI; Anderson HV; Braunwald E
    J Am Coll Cardiol; 1997 Jul; 30(1):133-40. PubMed ID: 9207634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma C-reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysis.
    Bennermo M; Held C; Hamsten A; Strandberg LE; Ericsson CG; Hansson LO; Tornvall P
    J Intern Med; 2003 Sep; 254(3):244-50. PubMed ID: 12930233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials.
    Cannon CP; Thompson B; McCabe CH; Mueller HS; Kirshenbaum JM; Herson S; Nasmith JB; Chaitman BR; Braunwald E
    Am J Cardiol; 1995 May; 75(15):977-81. PubMed ID: 7747698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital and long-term prognostic value of fibrinogen, CRP, and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis.
    Ziakas A; Gavrilidis S; Giannoglou G; Souliou E; Gemitzis K; Kalampalika D; Vayona MA; Pidonia I; Parharidis G; Louridas G
    Angiology; 2006; 57(3):283-93. PubMed ID: 16703188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry).
    Kleiman NS; Anderson HV; Rogers WJ; Theroux P; Thompson B; Stone PH
    Am J Cardiol; 1996 Feb; 77(4):227-31. PubMed ID: 8607398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ischemia-guided approach for risk stratification in patients with acute coronary syndromes.
    Pepine CJ
    Am J Cardiol; 2000 Dec; 86(12B):27M-35M. PubMed ID: 11206016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III Thrombosis and Anticoagulation Group.
    Becker RC; Tracy RP; Bovill EG; Mann KG; Ault K
    Coron Artery Dis; 1994 Apr; 5(4):339-45. PubMed ID: 7519107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules.
    Mulvihill NT; Foley JB; Murphy RT; Curtin R; Crean PA; Walsh M
    Heart; 2001 Jun; 85(6):623-7. PubMed ID: 11359739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.